Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts... Show more
SQM is one of the world's largest lithium producers and a major supplier of iodine, specialty plant nutrition, and industrial chemicals, making its quarterly update a demand barometer for electric-vehicle batteries and global agriculture. After lithium prices weakened in 2024 and recovered unevenly through 2025, the company has emphasized volume growth, contract coverage, and market share. The second-quarter report is especially important because it pairs a seasonally active period for fertilizer demand with evidence on whether lithium pricing and cost management can support the earnings rebound implied by consensus estimates. Updated guidance will help investors gauge momentum for the rest of 2026.
Heading into the release, consensus estimates place second-quarter 2026 revenue at roughly $2.1 billion to $2.2 billion and EPS at approximately $2.00 to $2.07. That compares with revenue of $1.04 billion and EPS of $0.31 in the second quarter of 2025, reflecting expectations for a substantial year-over-year recovery.
Investors will focus on several operating metrics. Lithium realized prices and sales volumes remain the central swing factor; management has targeted roughly 260,000 LCE (lithium carbonate equivalent) of production in 2026 and has said about 80% of volumes are already contracted. Iodine, which accounted for about 42% of 2025 gross margin, is expected to see roughly 3% market growth in 2026, with SQM targeting more than 15,000 tonnes of production. Specialty plant nutrition volumes are guided to grow 2% to 4%.
SQM's recent reporting pattern is also relevant. In Q1 2026, revenue of $1.76 billion beat forecasts and rose 69.8% year over year, but EPS of $1.28 missed consensus, and the stock still gained after management lifted its lithium volume guidance. Over the past eight quarters, according to Finviz data, SQM has beaten revenue estimates six times while EPS has not exceeded consensus, a pattern that puts extra weight on margins and cost commentary this quarter.
Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable criteria such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify trade ideas, trending stocks, breakout candidates, and new market opportunities more efficiently than manual screening. For investors monitoring events such as SQM's quarterly earnings, tools like this can support faster, data-driven watchlist building.
Sentiment into the report has been cautious. SQM shares closed at $74.47 on August 18, down about 0.8% on the day, after a broader pullback in commodity-linked equities and analyst warnings that the stock may have run ahead of fundamentals. The stock's price-to-earnings (P/E) ratio has also been trading above its five-year median, and some independent valuation models suggest a premium. Still, the broader analyst consensus on the stock remains a "Buy," with an average price target near $85, according to recent data.
Key risks heading into the release include lithium-price swings, cost composition tied to lease payments that rise with higher prices, and the timing of capacity projects. How the company addresses these issues on its earnings call may matter as much as the headline numbers.
After the report, the most important signal will be guidance. SQM has already indicated that 2026 lithium volumes should ramp quarter by quarter toward the fourth quarter, with production targeted at roughly 260,000 LCE and about 80% of volumes contracted. Any revision to that volume target, or commentary on realized prices, will shape expectations for the second half.
Project execution is another area to watch. The Mount Holland and Kwinana expansion has pushed the Kwinana refinery ramp-up into 2027, while some Chile capacity timelines have shifted toward 2028. Investors will listen for updates on capital spending, permitting, and whether those schedules remain on track.
Finally, diversification matters. Iodine has been a steady contributor, representing about 42% of 2025 gross margin, and specialty plant nutrition volumes are guided to grow 2% to 4%. Monitoring costs, margins, and cash conversion across these segments will be essential, particularly if lithium prices stay volatile. The balance of these factors, rather than any single metric, will likely drive the stock's next chapter.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a producer of potassium nitrate and iodine chemicals
Industry ChemicalsSpecialty